Multibody cofactor and substrate molecular recognition in the myo-inositol monophosphatase enzyme

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Ferruz N
- Tresadern G
- De Fabritiis G
Grupos
Abstract
Molecular recognition is rarely a two-body protein-ligand problem, as it often involves the dynamic interplay of multiple molecules that together control the binding process. Myo-inositol monophosphatase (IMPase), a drug target for bipolar disorder, depends on 3 Mg2+ ions as cofactor for its catalytic activity. Although the crystallographic pose of the pre-catalytic complex is well characterized, the binding process by which substrate, cofactor and protein cooperate is essentially unknown. Here, we have characterized cofactor and substrate cooperative binding by means of large-scale molecular dynamics. Our study showed the first and second Mg2+ ions identify the binding pocket with fast kinetics whereas the third ion presents a much higher energy barrier. Substrate binding can occur in cooperation with cofactor, or alone to a binary or ternary cofactor-IMPase complex, although the last scenario occurs several orders of magnitude faster. Our atomic description of the three-body mechanism offers a particularly challenging example of pathway reconstruction, and may prove particularly useful in realistic contexts where water, ions, cofactors or other entities cooperate and modulate the binding process.
Datos de la publicación
- ISSN/ISSNe:
- 2045-2322, 2045-2322
- Tipo:
- Article
- Páginas:
- 30275-30275
- DOI:
- 10.1038/srep30275
- PubMed:
- 27440438
- Factor de Impacto:
- 1,692 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
SCIENTIFIC REPORTS NATURE PUBLISHING GROUP
Citas Recibidas en Web of Science: 11
Documentos
- No hay documentos
Filiaciones
Proyectos y Estudios Clínicos
UNA APROXIMACIÓN ÓMICA AL DIAGNÓSTICO DE LA TUBERCULOSIS
PCIN-2013-041 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2015
HERRAMIENTAS DE RMN PARA EL DESARROLLO DE UNA PLATAFORMA PARA LA IDENTIFICACIÓN DE DIANAS, LA EVALUACIÓN DE FÁRMACOS Y LA PERSONALIZACIÓN DE TRATAMIENTOS BASADA EN APROXIMACIONES METABOLÓMICAS
Investigador Principal: ANTONIO PINEDA LUCENA
SAF2014-53977-R . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2015
RECALL. DESARROLLO DE PROTOTIPOS QUÍMICOS ORIENTADOS A LA GENERACIÓN DE TERAPIAS AVANZADAS PARA EL TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER
Investigador Principal: ANTONIO PINEDA LUCENA
RTC-2016-4803-1 . MINISTERIO DE ECONOMIA Y COMPETITIVIDAD . 2016
Identificación de biotipos moleculares de cáncer de próstata como base de una medicina de precisón (BIOChiP).
Investigador Principal: LÓPEZ
PROMETEO/2016/103 . 2016
Cita
Ferruz N,Tresadern G,PINEDA A,De Fabritiis G. Multibody cofactor and substrate molecular recognition in the myo-inositol monophosphatase enzyme. Sci Rep. 2016. 6. p. 30275-30275. IF:4,259. (1).